Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β(2)-Agonist Therapy: An Integrated Post Hoc Analysis

Por Naya, Ian P., Tombs, Lee, Lipson, David A., Compton, Chris
Publicado no Adv Ther (2018)

Efficacy of Umeclidinium/Vilanterol in Elderly Patients with COPD: A Pooled Analysis of Randomized Controlled Trials

Por Ray, Riju, Tombs, Lee, Asmus, Michael J., Boucot, Isabelle, Lipson, David A., Compton, Chris, Naya, Ian
Publicado no Drugs Aging (2018)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD

Por Naya, Ian, Compton, Chris, Ismaila, Afisi S., Birk, Ruby, Brealey, Noushin, Tabberer, Maggie, Zhu, Chang-Qing, Lipson, David A., Criner, Gerard
Publicado no ERJ Open Res (2018)

Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study

Por Feldman, Gregory J., Sousa, Ana R., Lipson, David A., Tombs, Lee, Barnes, Neil, Riley, John H., Patel, Sadhana, Naya, Ian, Compton, Chris, Alcázar Navarrete, Bernardino
Publicado no Adv Ther (2017)